2016 - 2021 クリゾチニブの再発または難治性小児ALK(anaplastic lymphoma kinase)陽性未分化大細胞型リンパ腫(anaplastic large cell lymphoma, ALCL)に対する第I/II相および再発または難治性神経芽腫に対する第I相医師主導治験
2015 - 2018 再発又は難治性のALK陽性ALCLに対するアレクチニブ塩酸塩の開発
2015 - 2018 小児リンパ腫の標準的治療法確立のための研究
Show all
Papers (77):
Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
Reiji Fukano, Yuka Iijima-Yamashita, Hideto Iwafuchi, Atsuko Nakazawa, Akiko M Saito, Tetsuya Takimoto, Masahiro Sekimizu, Yutaka Suehiro, Takahiro Yamasaki, Shunji Hasegawa, et al. Prognostic value of minimal disseminated disease assessed using digital PCR for 3'ALK assays in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica. 2023
Michi Kamei, Yuhki Koga, Shihhsiang Chen, Chaoping Yang, Kentaro Ohki, Reiji Fukano, Fumiko Tanaka, Tomoo Osumi, Makito Tanaka, Takeshi Mori, et al. Clinical Features and Outcomes of Pediatric Hodgkin Lymphoma in Asia. PEDIATRIC BLOOD & CANCER. 2019. 66. S116-S117
Michi Kamei, Yuhki Koga, Shih-Hsiang Chen, Chao-Ping Yang, Allen Eng Juh Yeoh, Hany Ariffin, Reiji Fukano, Masahiro Sekimizu, Shosuke Sunami, Junichi Ueyama, et al. Clinical features and outcomes of pediatric Hodgkin lymphoma in Asia. BRITISH JOURNAL OF HAEMATOLOGY. 2018. 182. 53-53
Reiji Fukano, Naoto Fujita, Tetsuya Mori, Ryoji Kobayashi, Tetsuo Mitsui, Koji Kato, Ritsuro Suzuki, Junji Suzumiya, Takahiro Fukuda, Motohiro Shindo, et al. Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2018. 182. 34-34